A groundbreaking medical device resembling a writing instrument is poised to transform therapeutic experiences for cancer patients and individuals with diabetic retinopathy across the United Arab Emirates. The innovative ‘aDose Core’ system, developed through advanced engineering research, represents a paradigm shift in targeted drug delivery methodologies.
This next-generation electro-osmotic pump technology utilizes electrical current to administer ultra-micro doses of medication with unprecedented precision, bypassing traditional bloodstream flooding approaches. The core mechanism operates through a patented ceramic component invented by Japanese scientist Dr. Mamoru Hirafuji, where electrical polarity controls bidirectional fluid movement at nanoliter levels.
According to Abhishek Choudhary, India Business Manager at atDose Co., Ltd, the technology’s revolutionary nature stems from its departure from mechanical pressure systems. “Unlike conventional syringes that depend on manual force and needle dimensions,” Choudhary explained to Khaleej Times, “this system enables pure voltage-controlled dosage administration, achieving up to 0.05 microliters of drug delivery.”
The clinical implications are particularly significant for oncology treatments, where direct tumor-site medication administration could dramatically reduce chemotherapy side effects and patient discomfort. Similarly, ophthalmology stands to benefit enormously, with the device capable of delivering therapeutics directly to retinal tissues using ultra-fine needles—a previously unattainable medical achievement.
The UAE’s substantial investments in oncology and specialized eye care infrastructure position the nation as an ideal adoption market for this technology. Current prototyping focuses on breast cancer applications, with future iterations anticipated to incorporate advanced chips, enhanced reservoir systems, and potential battery-powered functionality.
Notably, the system maintains compatibility with existing needle designs while featuring a detachable architecture that permits partial sterilization. This thoughtful design approach underscores the technology’s practical orientation toward addressing genuine unmet medical needs rather than simply replacing conventional syringes.